MedTrace Logo

A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder

NCT00470483 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2017-07-18

No results posted yet for this study

Summary

To compare by neuroimaging techniques the way Social Anxiety patients respond to public speaking before and after a drug administration

Conditions

  • Social Phobia

Interventions

DRUG

Placebo treatment during 8 weeks

comparator

DRUG

Paroxetine treatment during 8 weeks

treatment drug

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-22
Primary Completion
2009-01-07
Completion
2009-01-07

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00470483 on ClinicalTrials.gov